Atlas Trials

Expanded Access to Telisotuzumab Adizutecan

Clinical trial NCT05982873 · AVAILABLE

Trial details

NCT number
NCT05982873
Sponsor
AbbVie
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Solid Tumors

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.